Furthermore, Dnmt3a+/–-CH animals developed signs of metabolic dysfunction–associated steatotic liver disease (MASLD) characterized by larger and more numerous macrovesicular fat droplets (Figure 1L and Supplemental Figure 2F). Here, DNMT3A is linked to metabolic dysfunction-associated steatotic liver disease.